Wolverine Trading’s PAVmed PAVM Stock Holding History

Wolverine Trading’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-44	Closed	-$50K	–	6169
2021 Q4	$50K	Sell	44 -14	-24%	-$30.4K	﹤0.01%	5319
2021 Q3	$218K	Buy	58 +32	+123%	+$101K	﹤0.01%	5201
2021 Q2	$75K	Buy	+26	New	+$61.4K	﹤0.01%	5512

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's PAVM Position: Q4 2022 in Review

Wolverine Trading sold out of PAVmed (PAVM) in Q4 2022, closing a stake of 32 shares — an estimated $12.1K sold.

Wolverine Trading first reported a position in PAVM in Q1 2021 and held it in 6 quarters. The position peaked at $365K in Q3 2021. 62 funds tracked by Wall St. Rank hold PAVM as of Q4 2022.

Wolverine Trading reported no remaining PAVmed position as of Q4 2022 after selling out during the quarter.
Wolverine Trading sold 32 PAVmed shares in Q4 2022, an estimated $12.1K.
Wolverine Trading first reported a position in PAVmed in Q1 2021 and held it in 6 quarters.
Wolverine Trading's PAVmed position peaked at $365K in Q3 2021.
62 funds tracked by Wall St. Rank held PAVmed as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.